Literature DB >> 9783728

Inhibition of the adherence of cholera toxin and the heat-labile enterotoxin of Escherichia coli to cell-surface GM1 by oligosaccharide-derivatized dendrimers.

J P Thompson1, C L Schengrund.   

Abstract

The adherence of either cholera toxin or the heat-labile enterotoxin of Escherichia coli to monosialoganglioside gal(beta1-3)galNAc(beta1-4)[sialic acid (alpha2-3)]gal(beta1-4)glc(beta)1-ceramide (GM1) present on the surface of epithelial cells lining the intestine is the first step of a series that results in the induction of a watery diarrhea. While cholera is more severe, both can lead to death as a result of dehydration. To determine the potential of defined multivalent oligosaccharides, synthesized by the covalent attachment of multiple phenylisothiocyanate (PITC) derivatives of gal(beta1-3)galNAc(beta1-4)[sialic acid(alpha2-3)]gal(beta1-4)glc (oligo-GM1) to the arms of a poly(propylene imine) dendrimer, as therapeutic agents for these diseases, their ability to inhibit adherence of the toxins to cell surface-associated GM1 was determined. They not only inhibited choleragenoid (binding subunit of cholera toxin) binding to GM1-treated NCTC-2071 cells (chemically transformed murine fibroblasts) at 5 degrees, but also inhibited adherence of the choleragenoid, cholera toxin, and heat-labile enterotoxin of E. coli to GM1-treated NCTC-2071 cells at 37 degrees. Inhibition was observed whether the toxin was preincubated with the oligo-GM1-PITC-derivatized dendrimer prior to addition to cells or given just after the addition of the derivatized dendrimer to cells. The derivatized dendrimer had no effect on cell viability, as monitored by trypan blue exclusion. Blue-shifts in tryptophan fluorescence emission spectra maxima induced by adherence of either choleragenoid, cholera holotoxin, or the heat-labile enterotoxin of E. coli to oligo-GM1-PITC-derivatized dendrimers were similar to those induced by adherence to GM1 or oligo-GM1. Comparable shifts were not observed when the toxins were incubated with gangliosides that fail to function as receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783728     DOI: 10.1016/s0006-2952(98)00198-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

Review 1.  Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.

Authors:  Meredith A Mintzer; Eric L Dane; George A O'Toole; Mark W Grinstaff
Journal:  Mol Pharm       Date:  2011-12-13       Impact factor: 4.939

2.  Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro.

Authors:  Robert K Yu; Seigo Usuki; Yutaka Itokazu; Han-Chung Wu
Journal:  Glycobiology       Date:  2015-09-24       Impact factor: 4.313

3.  Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection.

Authors:  Richard D Kensinger; Bradley J Catalone; Fred C Krebs; Brian Wigdahl; Cara-Lynne Schengrund
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

4.  Aqueous RAFT Synthesis of Glycopolymers for Determination of Saccharide Structure and Concentration Effects on Amyloid β Aggregation.

Authors:  Pradipta K Das; Dexter N Dean; April L Fogel; Fei Liu; Brooks A Abel; Charles L McCormick; Eugenia Kharlampieva; Vijayaraghavan Rangachari; Sarah E Morgan
Journal:  Biomacromolecules       Date:  2017-09-26       Impact factor: 6.988

5.  Effects of polymer structure on the inhibition of cholera toxin by linear polypeptide-based glycopolymers.

Authors:  Brian D Polizzotti; Kristi L Kiick
Journal:  Biomacromolecules       Date:  2006-02       Impact factor: 6.988

6.  Cationic PAMAM dendrimers as pore-blocking binary toxin inhibitors.

Authors:  Philip Förstner; Fabienne Bayer; Nnanya Kalu; Susanne Felsen; Christina Förtsch; Abrar Aloufi; David Y W Ng; Tanja Weil; Ekaterina M Nestorovich; Holger Barth
Journal:  Biomacromolecules       Date:  2014-07-02       Impact factor: 6.988

Review 7.  Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials.

Authors:  Sandra García-Gallego; Gianluigi Franci; Annarita Falanga; Rafael Gómez; Veronica Folliero; Stefania Galdiero; Francisco Javier de la Mata; Massimiliano Galdiero
Journal:  Molecules       Date:  2017-09-21       Impact factor: 4.411

8.  Bioorthogonal, Bifunctional Linker for Engineering Synthetic Glycoproteins.

Authors:  Ryan McBerney; Jonathan P Dolan; Emma E Cawood; Michael E Webb; W Bruce Turnbull
Journal:  JACS Au       Date:  2022-08-26

Review 9.  Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases.

Authors:  Nina Filipczak; Satya Siva Kishan Yalamarty; Xiang Li; Farzana Parveen; Vladimir Torchilin
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.